Share Price:

APNASPENAspen Pharmacare Hldgs14665-118 (-0.80%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Aspen delivers strong results and advances its strategic ambitions

Aspen Pharmacare Holdings has reported positive Group interim financial results for the six months ended 31 December 2024.
Aspen contributed to the Health Works – Unlocking Local Pharma Manufacturing session, focused on scaling regional production, resilience, and jobs. Lorraine shared Aspen’s growth journey and key enablers to expand access to medicines—highlighting partnerships, technology transfer, and global mechanisms like WHO prequalification and PEPFAR. Discussions reinforced the urgency of progress through regulatory harmonisation, pooled procurement, demand certainty, and strong IP partnerships.
Facebook
Twitter
LinkedIn
Pinterest

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: